{"id":178979,"date":"2026-02-02T06:52:47","date_gmt":"2026-02-02T11:52:47","guid":{"rendered":"https:\/\/alphastreet.com\/india\/?p=178979"},"modified":"2026-02-02T06:52:47","modified_gmt":"2026-02-02T11:52:47","slug":"aster-dm-healthcare-q3-fy26-results-revenue-rises-13-yoy-as-margins-improve-sequentially-profitability-moderated-by-exceptional-costs","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-q3-fy26-results-revenue-rises-13-yoy-as-margins-improve-sequentially-profitability-moderated-by-exceptional-costs\/","title":{"rendered":"Aster DM Healthcare Q3 FY26 Results: Revenue Rises 13% YoY as Margins Improve Sequentially; Profitability Moderated by Exceptional Costs"},"content":{"rendered":"\n<p>Aster DM Healthcare Limited (NSE: ASTERDM) reported consolidated revenue from operations of \u20b91,186 crore for the quarter ended December 31, 2025, representing a 13% year-on-year increase. Growth was led by higher patient volumes and improved realizations across core hospital clusters.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"602\" height=\"339\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-12.png\" alt=\"\" class=\"wp-image-178980\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-12.png 602w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2026\/02\/image-12-300x169.png 300w\" sizes=\"auto, (max-width: 602px) 100vw, 602px\" \/><\/figure>\n\n\n\n<p>Operating EBITDA rose 11% year-on-year to \u20b9224 crore. Operating EBITDA margin stood at 18.9%, lower than the prior-year quarter due to higher staff and operating costs, but improved sequentially during the year.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Profitability<\/h2>\n\n\n\n<p>Profit before tax increased 8% year-on-year to \u20b9140 crore. Profit after tax declined 1% to \u20b967 crore, reflecting higher exceptional expenses related to labor code implementation and merger-related costs. Normalized profit after tax remained flat year-on-year at \u20b981 crore.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">SWOT Analysis<\/h2>\n\n\n\n<p>Strengths:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Double-digit revenue growth in core hospital segment<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Improving operating leverage over nine-month period<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Diversified regional hospital network<\/li>\n<\/ul>\n\n\n\n<p>Weaknesses:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reported profitability affected by exceptional items<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Margin sensitivity to staff and doctor cost inflation<\/li>\n<\/ul>\n\n\n\n<p>Opportunities:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Capacity expansion across key clusters<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Higher complexity procedures improving realizations<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Procurement and operating efficiencies<\/li>\n<\/ul>\n\n\n\n<p>Threats:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Regulatory cost pressures<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ramp-up risk in newly commissioned hospitals<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Competitive intensity in key regional markets<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Segment Trends<\/h2>\n\n\n\n<p>Hospitals contributed the majority of revenue, with 15% year-on-year growth supported by inpatient volume expansion and improved case mix.<\/p>\n\n\n\n<p>Clinics and wholesale pharmacy segments remained smaller contributors, with wholesale pharmacy revenue declining following exits from select loss-making units.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Nine-Month Performance<\/h2>\n\n\n\n<p>For the nine months ended December 31, 2025, revenue from operations increased 10% year-on-year to \u20b93,461 crore. Operating EBITDA rose 15% to \u20b9702 crore, with margin expansion supported by procurement efficiencies and operating leverage. Normalized profit after tax increased 12% year-on-year to \u20b9281 crore.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Margins and Costs<\/h2>\n\n\n\n<p>Material, employee, and doctor costs increased in line with revenue growth. Operating margins were supported by procurement centralization and cost control initiatives, partially offset by wage-related provisions arising from the new labor codes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Balance Sheet and Capital<\/h2>\n\n\n\n<p>Total consolidated assets stood at \u20b97,894 crore as of December 31, 2025. Net debt levels remained stable during the quarter. Capital structure reflected ongoing investments in capacity expansion and acquisitions, including increased stake in Prerana Hospital Limited.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Expansion &amp; Ongoing Projects<\/h2>\n\n\n\n<p>The company continued execution of hospital expansion plans, including greenfield and brownfield bed additions in Andhra Pradesh, Telangana, and Kerala. Several recently commissioned units reported improving utilization and margins during the quarter.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Stock Performance<\/h2>\n\n\n\n<p>Aster DM Healthcare shares were volatile following the results, reflecting investor assessment of margin sustainability and exceptional cost impacts. The stock\u2019s performance over the past year has tracked earnings recovery and restructuring developments post GCC business separation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Investors Are Watching<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sustainability of operating EBITDA margins<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ramp-up performance of new hospitals<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Normalized profit trajectory excluding exceptional items<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Capital expenditure and funding discipline<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Execution of merger with Quality Care India Limited<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Risks &amp; Concerns<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Elevated staff and operating costs<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Execution risk in new hospital expansions<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Regulatory-driven cost increases from labor code changes<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Integration risks related to acquisitions and mergers<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Forward Outlook<\/h2>\n\n\n\n<p>Near-term performance is expected to remain linked to volume growth, margin stability, and execution of expansion projects already disclosed. Profitability will continue to be influenced by normalization of exceptional costs and operating efficiency measures.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aster DM Healthcare Limited (NSE: ASTERDM) reported consolidated revenue from operations of \u20b91,186 crore for the quarter ended December 31, 2025, representing a 13% year-on-year increase. Growth was led by higher patient volumes and improved realizations across core hospital clusters. Operating EBITDA rose 11% year-on-year to \u20b9224 crore. Operating EBITDA margin stood at 18.9%, lower [&hellip;]<\/p>\n","protected":false},"author":2382,"featured_media":125416,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1941,392,5747],"tags":[15476,10169,9175,14492,13743,10310,8832,15477,15062,10089],"class_list":["post-178979","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-stock-analysis","category-earnings","category-healthcare-stocks","tag-aster-qcil","tag-earnings","tag-earnings-call","tag-financial-results","tag-health-care","tag-hospital","tag-medical-care-facilities","tag-phygital-healthcare-platform","tag-q3-fy26-results","tag-quarterly-earnings"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":178984,"url":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-q3-revenue-rises-13-as-company-advances-qcil-merger-integration\/","url_meta":{"origin":178979,"position":0},"title":"Aster DM Healthcare Q3 Revenue Rises 13% as Company Advances QCIL Merger Integration","author":"Staff Correspondent","date":"February 2, 2026","format":false,"excerpt":"Aster DM Healthcare Limited (NSE: ASTERDM) the healthcare provider reported consolidated revenue of \u20b91,185.76 crore for the quarter ended December 31, 2025, driven by double-digit growth in its core hospital business. Management continues to prioritize the pending merger with Quality Care India Limited, which is expected to create one of\u2026","rel":"","context":"In &quot;Analysis&quot;","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":170693,"url":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-q1-fy26-earnings-results\/","url_meta":{"origin":178979,"position":1},"title":"Aster DM Healthcare Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 27, 2025","format":false,"excerpt":"Aster DM Healthcare Ltd is one of the largest integrated private healthcare service providers operating primarily in the GCC countries and emerging in India. The company offers a comprehensive range of healthcare services across primary to quaternary care levels. Presenting below its Q1 FY26 Earnings Results. Q1 FY26 Earnings Results\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"ASTERDM Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/ASTER.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142528,"url":"https:\/\/alphastreet.com\/india\/earnings-aster-dm-healthcare-ltd-nse-asterdm-q3fy23-results-out-total-income-rise-20-yoy\/","url_meta":{"origin":178979,"position":2},"title":"Earnings | Aster DM Healthcare Ltd (NSE: ASTERDM): Q3FY23 Results Out; Total Income rise 20% YoY","author":"Divyansh_Kasana","date":"February 22, 2023","format":false,"excerpt":"Aster DM Healthcare Ltd (NSE: ASTERDM) is a multinational healthcare company that operates hospitals, medical centers, diagnostic centers, laboratories, and pharmacies in six GCC countries and India. The company was founded in 1987 by Azad Moopen and is registered in Bangalore, India, with its corporate headquarters in Dubai, UAE. The\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":168727,"url":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-ltd-q4fy25-3-rise-in-revenue\/","url_meta":{"origin":178979,"position":3},"title":"Aster DM Healthcare Ltd Q4FY25; 3% rise in Revenue","author":"Divyansh_Kasana","date":"June 10, 2025","format":false,"excerpt":"Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/O-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":165257,"url":"https:\/\/alphastreet.com\/india\/aster-dm-healthcare-ltd-q2fy25-17-rise-in-revenue\/","url_meta":{"origin":178979,"position":4},"title":"Aster DM Healthcare Ltd Q2FY25; 17% rise in Revenue","author":"Divyansh_Kasana","date":"October 28, 2024","format":false,"excerpt":"Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/AST.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/2382"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=178979"}],"version-history":[{"count":1,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178979\/revisions"}],"predecessor-version":[{"id":178981,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/178979\/revisions\/178981"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/125416"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=178979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=178979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=178979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}